The value of approved therapies for pulmonary arterial hypertension.
Rich
Stuart
S
D002121:Calcium Channel Blockers / Q000627:therapeutic use; D011464:Epoprostenol / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000627:therapeutic use; D005081:Exercise Therapy; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy* / Q000628:therapy; D007262:Infusions, Intravenous; D015201:Meta-Analysis as Topic; D012107:Research Design
D002121:Calcium Channel Blockers; C048081:beraprost; D011464:Epoprostenol